ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,390 | -85.6% | 373 | -78.5% | 0.00% | -100.0% |
| Q2 2023 | $308,446 | +8.0% | 1,731 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $285,545 | -6.1% | 1,731 | -10.4% | 0.00% | 0.0% |
| Q4 2022 | $304,250 | -15.0% | 1,932 | -19.2% | 0.00% | 0.0% |
| Q3 2022 | $358,000 | -8.4% | 2,390 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $391,000 | -31.9% | 2,390 | -7.7% | 0.00% | 0.0% |
| Q1 2022 | $574,000 | +312.9% | 2,590 | +337.5% | 0.00% | – |
| Q4 2021 | $139,000 | -58.0% | 592 | -58.4% | 0.00% | -100.0% |
| Q3 2021 | $331,000 | +5.1% | 1,424 | -7.5% | 0.00% | 0.0% |
| Q2 2021 | $315,000 | -85.2% | 1,540 | -85.1% | 0.00% | -75.0% |
| Q1 2021 | $2,126,000 | -79.5% | 10,355 | -78.6% | 0.00% | -81.0% |
| Q4 2020 | $10,376,000 | -29.3% | 48,401 | -39.7% | 0.02% | -34.4% |
| Q3 2020 | $14,671,000 | +1.6% | 80,275 | +2.3% | 0.03% | 0.0% |
| Q2 2020 | $14,437,000 | +210.6% | 78,485 | +240.4% | 0.03% | +166.7% |
| Q1 2020 | $4,648,000 | +306.6% | 23,055 | +277.3% | 0.01% | +500.0% |
| Q4 2019 | $1,143,000 | +351.8% | 6,110 | +285.7% | 0.00% | – |
| Q3 2019 | $253,000 | -82.9% | 1,584 | -73.0% | 0.00% | -100.0% |
| Q2 2019 | $1,479,000 | -53.5% | 5,875 | -55.9% | 0.00% | -50.0% |
| Q1 2019 | $3,184,000 | -1.0% | 13,307 | -5.0% | 0.01% | -14.3% |
| Q4 2018 | $3,215,000 | -59.9% | 14,005 | -50.7% | 0.01% | -53.3% |
| Q3 2018 | $8,023,000 | -12.3% | 28,396 | -8.9% | 0.02% | -21.1% |
| Q2 2018 | $9,150,000 | +73.3% | 31,160 | +49.0% | 0.02% | +111.1% |
| Q1 2018 | $5,280,000 | +54.2% | 20,919 | +32.5% | 0.01% | +50.0% |
| Q4 2017 | $3,425,000 | +13.3% | 15,787 | -3.0% | 0.01% | +20.0% |
| Q3 2017 | $3,024,000 | +9.1% | 16,271 | +1.2% | 0.01% | 0.0% |
| Q2 2017 | $2,772,000 | -21.2% | 16,071 | -30.3% | 0.01% | -16.7% |
| Q1 2017 | $3,519,000 | -64.4% | 23,043 | -66.1% | 0.01% | -68.4% |
| Q4 2016 | $9,871,000 | – | 68,036 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |